Biovica International AB (OSTO:BIOVIC B) Debt-to-Equity : 0.06 (As of Jan. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB Debt-to-Equity?

Biovica International AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was kr3.42 Mil. Biovica International AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was kr4.80 Mil. Biovica International AB's Total Stockholders Equity for the quarter that ended in Jan. 2024 was kr136.03 Mil. Biovica International AB's debt to equity for the quarter that ended in Jan. 2024 was 0.06.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Biovica International AB's Debt-to-Equity or its related term are showing as below:

OSTO:BIOVIC B' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.04 Max: 0.15
Current: 0.06

During the past 9 years, the highest Debt-to-Equity Ratio of Biovica International AB was 0.15. The lowest was 0.01. And the median was 0.04.

OSTO:BIOVIC B's Debt-to-Equity is ranked better than
69.66% of 1068 companies
in the Biotechnology industry
Industry Median: 0.14 vs OSTO:BIOVIC B: 0.06

Biovica International AB Debt-to-Equity Historical Data

The historical data trend for Biovica International AB's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB Debt-to-Equity Chart

Biovica International AB Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Debt-to-Equity

Get a 7-Day Free Trial

0.04

0.01

0.11

0.08

Biovica International AB Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Debt-to-Equity	Get a 7-Day Free Trial															0.06	0.08	0.09	0.12	0.06

Competitive Comparison of Biovica International AB's Debt-to-Equity

For the Biotechnology subindustry, Biovica International AB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biovica International AB's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biovica International AB's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Biovica International AB's Debt-to-Equity falls into.

Biovica International AB Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Biovica International AB's Debt to Equity Ratio for the fiscal year that ended in Apr. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3.149	+	7.304)	/	138.635
	=	0.08

Biovica International AB's Debt to Equity Ratio for the quarter that ended in Jan. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3.416	+	4.802)	/	136.029
	=	0.06

Biovica International AB (OSTO:BIOVIC B) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Biovica International AB Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Biovica International AB's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Biovica International AB (OSTO:BIOVIC B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

9II:Germany

Address

Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37

Website

http://www.biovica.com

Biovica International AB is a biotech company. It develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments. Through collaboration with world- leading cancer institutes and pharmaceutical companies, it promotes the trend in healthcare for personalized treatment, with a primary focus on patient survival and benefits to society. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB (OSTO:BIOVIC B) Headlines

No Headlines